DTIL Q3'26 Earnings: EPS estimate is (0.85) USD

What happened

Precision BioSciences is scheduled to announce its Q3'26 results on November 03, with disclosure expected at 7:00 AM ET. Estimates put revenue at 1.38 million USD and earnings per share, or EPS, at a loss of 0.85 per share.

Confirmed

Global impact / market context

These estimates provide a benchmark, not a report of actual performance. Revenue below the forecast could indicate weaker sales, while a smaller per-share loss could suggest better control of costs; either result may influence expectations for the company’s future cash needs.

Analyst inference

The article lists earlier revenue and EPS estimates alongside reported figures, but provides no Q3'26 actuals or explanation for past differences. That history makes the upcoming release a potential test of forecast reliability; the article alone does not establish a trend or explain the business drivers.

Analyst inference

What to watch

1. Compare reported Q3'26 revenue with the 1.38 million USD estimate; the gap will show whether sales were higher or lower than the stated forecast. Confirmed
2. Compare reported EPS with the estimated loss of 0.85 per share; EPS means profit or loss divided among shares, and a narrower loss would exceed expectations. Confirmed
3. If management discusses sales sources and spending, assess whether those details suggest revenue can grow and losses shrink, which could affect expectations for future cash needs. Analyst inference

Evidence

• Original source link unavailable